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Abstract Previously, we have reported that phospholipase A2 
(PLA2) is one of the major downstream targets by which Rac 
GTPase mediates the activation of c-fos serum response element 
(SRE) in response to agonists such as EGF [FEBS Lett. 407 
(1997) 7-12]. Thus, the potential activity of arachidonic acid 
(AA), a principal product of Rac-activated PLA2, on c-fos SRE 
stimulation has been suggested. Here, we provide evidence about 
the biological activity of AA on c-fos SRE activation. Further, 
we observed that co-transfection with expression plasmid of 
either RhoN 19, a dominant negative RhoA mutant, or botulinum 
C3 transferase which inhibits Rho via ADP ribosylation, 
selectively repressed AA- or Rac-induced SRE activation, 
suggesting that Rho activity is critical for the signaling cascade 
of 'Rac-PLA2-AA' to c-fos SRE. Thus, Rac signaling to the 
nucleus appears to be, at least partly, mediated by a Rho-linked 
pathway and this Rac-Rho signaling connection is mediated by 
AA. In accordance with the role of Rho as a potential mediator 
of AA signaling to the nucleus, AA induces a rapid translocation 
of RhoA. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Arachidonic acid (AA), an important lipid second messen-
ger, is generated via phospholipase A2 (PLA2) activation in 
response to a variety of stimuli, including epidermal growth 
factor (EGF), inflammatory agents, and cytokines [1-4]. It has 
been demonstrated that activation of Rac, a member of the 
Rho family GTPases, leads to AA release, suggesting that 
PLA2 is one of the downstream targets of Rac [5-7]. In addi-
tion, our recent studies have shown that, in Rat-2 fibroblast 
cells, AA was released rapidly by EGF or exogenous hydro-
gen peroxide via Rac-activated PLA2 and further that the 
'Rac-PLA2-AA cascade' mediates, at least partly, the signal-
ing induced by EGF or hydrogen peroxide [1,2]. Thus, AA, a 
principal product of PLA2, is suggested to play a pivotal role 
in mediating Rac-induced signals in cells. 
Recently, several groups have reported on a critical role of 
AA in the regulation of a variety of cellular activities such as 
proliferation, differentiation, actin remodeling, Superoxide 
generation, gene expression as well as apoptosis, programmed 
cell death [5,6,8-11]. Although the exact signaling mechanism 
of AA mediating those cellular responses remains largely un-
known, recent evidence suggests that the metabolism of AA 
by lipoxygenase (LO) and subsequent production of leuko-
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trienes are likely to be essential, especially in the signaling 
pathway regulating cellular survival and apoptosis [8]. Also, 
in actin remodeling in response to EGF, leukotrienes gener-
ated by LO are necessary and sufficient for actin stress fiber 
formation [6]. Similarly, in our recent work on c-fos serum 
response element (SRE) activation induced by RacV12, a con-
stitutively activated mutant of Racl, AA release via Rac-acti-
vated PLA2 and subsequent metabolism of AA by LO were 
shown to be essential, thus supporting a potential role of 
leukotrienes as one of the major downstream mediators of 
AA signaling [7]. Therefore, the 'Rac-AA-leukotrienes' signal-
ing cascade is likely to be important in regulating several key 
cellular activities including the c-fos SRE stimulation. 
It was reported by Peppelenbosch et al. that the addition of 
exogenous leukotrienes was able to induce actin stress fiber 
formation [6]. Further, they have demonstrated that leuko-
triene-dependent stress fiber formation requires Rho proteins, 
which suggests that the 'Rac-AA-leukotrienes' signaling cas-
cade is one major pathway by which Rac influences Rho-de-
pendent cytoskeletal rearrangements [6]. Therefore, there is an 
apparent signaling link between Rac and Rho in the actin 
regulation. However, it is not known whether this 'AA-medi-
ated Rac-Rho signaling link' also exists in other cellular sig-
naling pathways involved in gene regulation, cell survival, or 
apoptosis. 
In the present project, we undertook to understand the 
downstream part of the 'Rac-AA-leukotrienes signaling cas-
cade' in c-fos SRE regulation, and examined whether Rho is 
necessary for the nuclear signaling cascade of AA to c-fos 
SRE. Our results clearly demonstrate that RhoA is essential 
for AA-induced c-fos SRE stimulation. We propose that AA 
acts as a common linking molecule between Rac and Rho in 
both signaling cascades leading to actin remodeling and gene 
regulation. 
2. Materials and methods 
2.1. Chemicals and reagents 
AA was obtained from BioMol (Plymouth Meeting, PA, USA) and 
Sigma Chemical Co. (St. Louis, MO, USA). EGF was purchased from 
Boehringer Mannheim GmbH (Mannheim, Germany). Fetal bovine 
serum (FBS), gentamicin, and Dulbecco's modified Eagle's medium 
(DMEM) were from Gibco-BRL (Gaithersburg, MD, USA). Polyclo-
nal antibody to RhoA was purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA). All other chemicals were from standard 
sources and were molecular biology grade or higher. 
2.2. Cell culture, transfections and lucifer ase assay 
Rat-2 fibroblast cells were obtained from the American Type Cul-
ture Collection (ATCC, CRL 1764). Cells were grown in DMEM 
supplemented with 2 mM glutamine, 10% (v/v) fetal bovine serum 
and gentamicin as described before [1,2]. Transient transfection anal-
ysis was performed as described previously [1,2]. To control for var-
iations in both cell numbers and transfection efficiency, all clones were 
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co-transfected with 1 ug of pCMV-ßGAL, an eukaryotic expression 
vector in which the Escherichia coli ß-galactosidase (lacZ) structural 
gene is under the transcriptional control of the CMV promoter [12]. 
Lysates prepared from the harvested cells were assayed for both luci-
ferase activity and ß-galactosidase activity, which was used as an 
internal standard to normalize the luciferase activity directed by the 
test plasmid [1,2], Luciferase activity was determined as described 
previously [1,2]. Transfection experiments were performed in triplicate 
with two independently isolated sets and the results were averaged. 
2.3. Subcellular fractionation of cell lysates and Western blotting 
Rat-2 cells were serum-starved for 18 h in serum-free DMEM and 
appropriate agonists were treated for the indicated times. The medium 
was removed and the cells were washed twice with ice-cold PBS, 
scraped, harvested by micro-centrifugation, and resuspended in 0.2 
ml of buffer A (137 rnM NaCl, 8.1 mM Na 2HP0 4 , 2.7 mM KCl, 
1.5 mM KH 2P0 4 , 2.5 mM EDTA, 1 mM dithiothreitol, 0.1 mM 
phenylmethylsulfonyl fluoride, 10 |Xg/ml leupeptin, pH 7.5). The re-
suspended cells were then sonicated twice for 15 s each or alternatively 
lysed by 20 passes through a 21.1-gauge needle on ice. Lysates were 
centrifuged at lOOOOXg for 1 h to prepare cytosolic and total partic-
ulate fractions. The paniculate fractions containing membrane frac-
tion were washed twice and resuspended in 50 (il of buffer A. The 
supernatant fractions were precipitated with 5 volumes of acetone, 
incubated on ice for 5 min, centrifuged, and the pellet was resus-
pended in buffer A. Protein concentrations were determined routinely 
using the Bradford procedure with Bio-Rad Dye Reagent and bovine 
serum albumin as a standard. 
SDS-polyacrylamide gel electrophoresis was performed on 12% 
acrylamide gels, and proteins were transferred onto polyvinylidene 
difluoride membranes for 2 h at 100 V using a No vex wet transfer 
unit. The membrane was blocked overnight with TBS (PBS containing 
0.01% (v/v) Tween 20) with 5% (w/v) non-fat dried milk. Blots were 
incubated for 2 h with primary antibody (to RhoA) in TBS and then 
for 1 h with a horseradish peroxidase-conjugated secondary antibody, 
prior to development using an enhanced chemiluminescence kit 
(Amersham Corp.). Bands corresponding to RhoA were measured 
by densitometry and the purified recombinant proteins were used as 
standards to calibrate the densitometer. 
3. Results and discussion 
3.1 and Exogenous AA stimulates c-fos SRE in a dose-
time-dependent manner 
To understand the potential role of AA as a downstream 
mediator of the Rac signaling cascade leading to the activa-
tion of c-fos SRE, a well-known primary nuclear target for 
many extracellular signals such as growth factors, cytokines, 
and environmental stress [13-15], we first tested whether the 
exogenous addition of AA, a principal product of Rac-acti-
vated PLA2, induces c-fos SRE activation. Following transi-
ent transfections with a reporter plasmid, pSRE-Luc [1] con-
taining c-fos SRE fused to luciferase coding sequences, Rat-2 
cells were serum-starved in DMEM containing 0.5% FBS for 
36 h before adding AA exogenously. As shown in Fig. 1, 
exogenous AA stimulated the c-fos SRE-dependent reporter 
gene activity in a dose- and time-dependent manner. An ap-
proximately 5-fold increase in the luciferase activity occurred 
2 h after the addition of AA and by 6 h, the c-fos SRE 
luciferase level declined (Fig. 1). Maximal luciferase activity 
was detected at an AA concentration of 100 uM (Fig. 1). As a 
control, pO-luciferase [1], a vector without SRE, was trans-
fected and no stimulation of the luciferase activity was ob-
served by AA (data not shown). Together, these results are 
well in agreement with the suggested role of AA as a major 
downstream mediator of Rac in the signal transduction cas-
cade leading to c-fos SRE stimulation. 
3.2. Rho GTPase activity is required for AA-induced SRE 
activation 
It has been reported that AA metabolites are involved in 
the activation of Rho by Rac in the regulation of actin re-
modeling in Swiss 3T3 cells [5,6]. To obtain further insight 
into the mechanism by which AA activates c-fos SRE in Rat-2 
fibroblasts, we examined whether AA-induced SRE activation 
is also dependent on functional Rho. For this analysis, botu-
linum C3 transferase expression was used. Expression of C3 
transferase has been shown to specifically inhibit Rho via 
ADP-ribosylation at Asn-41 [15]. Cells were co-transfected 
with EF (vector) or EF-C3 (C3 transferase) together with 
SRE-luciferase reporter gene to determine whether C3 trans-
ferase co-transfection blocks AA-induced SRE activation. As 
shown in Fig. 2A, we observed that EF-C3 blocked dramat-
ically AA-induced SRE activation ( ~ 80% reduction of luci-
ferase activity) whereas EGF (50 ng/ml)-induced SRE activa-
tion was only slightly affected (Fig. 2A). LPA (10 uM)-
induced SRE activation was also blocked completely by C3 
transferase, which is in agreement with a previous report 
showing that LPA activates c-fos SRE principally via a 
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Fig. 1. Dose- and time-dependent c-fos SRE stimulation by AA. After transient transfections with pSRE-Luc (3 u.g), Rat-2 cells were serum-
starved in 0.5% FBS/DMEM for 36 h before treatment with AA. A: Dose response of AA on SRE activation. Various amounts of AA (0, 25, 
50, 100, 200 U.M) were added for 2 h to serum-starved transfected cells. B: Time-dependent response of AA (100 uM) on SRE activation. 
Serum-starved Rat-2 cells were treated with AA for the lengths of time indicated. Luciferase and ß-galactosidase activities were measured as 
described in Section 2. 
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Fig. 2. Inhibition of AA-induced SRE activation by RhoN19 or C3-transferase. A reporter gene plasmid, pSRE-Luc (3 ug) was transiently co-
transfected with 1 ug of pEFC3, a C3-transferase expression plasmid (A) or 5 ug of pEXV-RhoN19, a dominant negative RhoA expression 
plasmid (B). The total amount of DNA was kept at 20 ug with calf thymus carrier DNA. Transfected cells were serum-deprived in 0.5% FBS/ 
DMEM for 36 h before treatment with AA (100 uM), EGF (50 ng/ml), or LPA (10 uM). After 2 h of treatment, luciferase and ß-galactosidase 
activities were measured. Values are representative of triplicate transfections. 
Rho-dependent pathway [15]. This result indicates that the 
signaling pathway of AA to SRE is dependent upon function-
al Rho. 
Similarly, by co-transfection experiments with pEXV-
RhoN19 encoding a dominant negative RhoAN19, we ob-
served a similar mode of inhibition of the AA-induced SRE 
activation. For this test, cells were transiently co-transfected 
with 5 ¡ug of pEXV (control vector) or pEXV-RhoN19 along 
with pSRE-Luc (3 ug). As shown in Fig. 2B, AA-induced 
SRE activation is significantly inhibited by co-transfection 
with pEXV-RhoN19 (approximately 75-80% reduction of lu-
ciferase activity), not with pEXV (vector), again suggesting 
that Rho activity is critical for the c-fos SRE stimulation by 
AA. Together, these results suggest that AA-induced c-fos 
SRE activation requires Rho activity in Rat-2 fibroblast cells. 
3.3. RacV'12'-induced SRE activation requires Rho 
To obtain evidence regarding the role of Rho in Rac-in-
duced signaling to c-fos SRE, we tested whether Rac-induced 
c-fos SRE activation also requires Rho. pEXV-RacV12 en-
coding a constitutively active GTPase-deficient alíele of 
Racl, termed RacV 12, was transiently co-transfected with a 
reporter plasmid, pSRE-Luc. As shown in Table 1, RacV12-
induced stimulation of SRE luciferase activity was signifi-
cantly diminished in a dose-dependent manner (up to 
~ 6 0 % reduction of luciferase activity) by co-transfection 
with EF-C3, but not with EF. Similarly, by co-transfection 
with pEXV-RhoN19, significant inhibition of the AA-induced 
SRE activation was observed in a dose-dependent manner 
(Table 1, bottom). These results indicate that the Rac signal-
ing cascade leading to c-fos SRE activation is largely mediated 
via a Rho-dependent pathway although we cannot rule out 
the existence of alternative signaling routes which will stimu-
late c-fos SRE independently of Rho. These results are well in 
agreement with our proposed model for 'PLA2-AA' as one of 
the major downstream elements of Rac in the nuclear signal-
ing pathway. 
3.4. AA induces a translocation of RhoA GTPase protein 
The essential role of Rho in the AA signaling cascade was 
further examined by determining whether exogenous AA stim-
ulates the translocation of Rho protein. To do this, serum-
starved Rat-2 cells were stimulated with 100 uM of AA for 10 
min. Then, the cells were lysed, and the particulate fractions 
were analyzed for RhoA by Western blotting. As shown in 
Fig. 3A, the level of RhoA protein localized in the particulate 
membrane fraction is induced to increase by AA ( ~ 1.8-fold 
increase as shown in lane 2). Thus, this result indicates stim-
ulation of RhoA during the AA signaling cascade in Rat-2 
fibroblast cells. As shown in Fig. 3A, lanes 3-6, the AA-in-
duced translocation of RhoA was not affected by mepacrine 
(a specific PLA2 inhibitor) or indomethacin (a cyclooxygenase 
Table 1 
Inhibition of RacV12-induced SRE activation by co-transfection with pEF-C3 or pEXV-RhoN19 
+Co-transfected DNA Amounts of co-transfected DNA (ug) 
pEXV 
pEXV-RacV12 
pEXV 
pEXV-RacV12 
pEXV 
pEXV-RacV12 
pEXV 
pEXV-RacV12 
+pEF 
+pEF 
+pEF-C3 
+pEF-C3 
+Co-transfected DNA 
+pEXV 
+pEXV 
+pEXV-RhoN19 
+pEXV-RhoN19 
0 
1 
7.210.2 
1 
7.210.2 
Amounts of co 
0 
1 
7.210.2 
1 
7.210.2 
0.5 
1.110.1 
7.110.2 
0.910.2 
5.510.2 
-transfected DNA (ug) 
1.0 
1.010.1 
7.010.2 
0.810.2 
5.810.4 
0.75 
0.910.2 
7.010.4 
1.010.1 
3.910.3 
2.0 
0.910.2 
6.910.7 
1.110.4 
4.210.5 
1.0 
0.910.2 
6.810.3 
0.810.2 
2.710.2 
5.0 
0.810.3 
6.610.5 
0.810.3 
3.010.4 
A reporter gene plasmid, pSRE-Luc (3 ug) and 5 ug of pEXV or pEXV-RacV12 were transiently co-transfected with indicated amounts of pEF or 
pEF-C3 (top) or indicated amounts of pEXV or pEXV-RhoN19 (bottom). The total amount of DNA was kept at 20 ug with calf thymus carrier 
DNA. Transfected cells were serum-deprived in 0.5% FBS/DMEM for 36 h before assays for luciferase and ß-galactosidase activities. The results 
are means 1 S.D. obtained with three samples. 
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Fig. 3. AA stimulates translocation of RhoA in a LO-dependent 
manner. A: Cells were stimulated with buffer (lane 1), AA (100 
uM, lane 2), AA+mepacrine, 1 (iM (lane 3), AA+indomethacin, 10 
uM (lane 4), AA+NDGA, 5 uM (lane 5), or AA+KN-62, 0.75 uM 
(lane 6) for 10 min, lysed, and the membrane fraction was prepared 
as described in Section 2. The inhibitors were pretreated for 20 min 
before the addition of AA. The increasing level of RhoA ( ~ 25 K¿) 
was detected by Western blotting of equal amounts of membrane 
fraction proteins. B: Data are expressed as a relative percentage of 
the basal value (buffer treatment; 100%) and are the average ± 
standard error of three experiments. 
inhibitor) pretreatment, but was severely inhibited by NDGA 
(a LO inhibitor) or KN-62 (a CaM kinase II inhibitor) pre-
treatment. In Fig. 3B, these data are expressed as relative 
percentages of the basal value obtained with buffer treatment. 
This result points to a critical role of LO and also possibly 
CaM kinase II in the AA-induced signaling to RhoA activa-
tion. 
In the present study, we have shown for the first time that 
A A, a principal product of Rac-activated PLA2, activates c-
fos SRE via a Rho-dependent signaling pathway in Rat-2 
fibroblast cells, thus demonstrating a signaling link between 
Rac and Rho. Our proposed mode of the 'Rac-AA-Rho' sig-
naling cascade to c-fos SRE activation seems very similar to 
that of the actin remodeling pathway suggested by Peppelen-
bosch et al. [5,6]. In the actin remodeling system, Rac was 
shown to activate Rho GTPase via AA metabolism to leuko-
triene production, an event necessary for growth factor-de-
pendent actin stress fiber formation in fibroblast cells [5,6]. 
Similarly, we previously observed that AA release via Rac-
activated PLA2 and subsequent LO metabolites is critical in 
mediating Rac signaling to c-fos SRE [7]. Thus, AA release 
and subsequent metabolism by LO appear to be commonly 
involved in the Rac-mediated signaling pathways to either 
actin remodeling or gene regulation. Consistent with this 
idea, we observed that the addition of leukotriene C4/D4/E4, 
metabolic products of 5-LO, induces a significant activation of 
SRE luciferase activity (data not shown). Further studies 
aimed at understanding the signaling link between AA and 
Rho activation in the control of Rac-induced c-fos SRE acti-
vation will lead to additional insights into the regulation of 
the Rac-Rho signaling link. 
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